Mission Produce Inc

AVO · NASDAQ

$12.84▼ -1.53%

$0.20 today

Mkt cap $1.15B
P/E 40.8
Day $12.83 – $13.10

Confidence

High conviction

The read

Mission Produce Q4 EPS misses estimates by 269.5%, shares dip slightly post-earnings

Mission Produce reported Q4 EPS of -$0.10 versus an estimate of $0.06, missing by 269.5%. The stock declined about 1% following the earnings release. Despite a buy-tilted analyst consensus with a $17.5 target, weak revenue and EPS growth trends persist, and valuation remains mixed with a rich trailing P/E but cheaper forward P/E. Investors should watch for signs of margin recovery or integration progress from the recent Calavo acquisition.

Confidence note: Analysis is based on concrete EPS miss data, recent acquisition context, and clear valuation and growth metrics, though forward guidance details are limited.

What happened

Earnings print

Reported EPS was -$0.1017, missing the consensus estimate of $0.06 by 269.5%.

Guidance

No explicit guidance was provided in the payload; forward EPS growth is forecasted at +33.3%.

Price reaction

Shares declined approximately 1% on the day of the earnings report, reflecting investor disappointment.

Street narrative

The company recently completed the Calavo Growers acquisition, aiming to diversify products and drive synergies, but margin pressure and sales declines remain concerns.

So what

What changed

Q4 EPS missed estimates by 269.5%, reported at -$0.10 versus $0.06 expected.

What the market is pricing

Stock declined about 1% post-earnings, reflecting disappointment amid weak growth and margin pressure.

Fundamental takeaway

Downgrade bias; monitor integration progress and margin improvement as key triggers.

Next 30–90 days

Bull

16%

Successful integration of Calavo and margin recovery drive EPS turnaround and share price appreciation.

Quarterly update showing margin expansion or cost synergies from Calavo acquisition.
Revenue stabilization or growth reversing recent declines.

Base

34%

Gradual improvement in margins and stable revenue growth with modest share price recovery.

Management commentary indicating steady progress on integration.
Forward EPS growth forecast of +33.3% materializing.

Bear

50%

Persistent margin pressure and declining sales lead to further earnings deterioration and share price weakness.

Additional quarterly EPS misses following this print.
Negative news on integration or increased costs from acquisition.

What to do

If you hold it

Hold unless next quarter EPS or margin metrics improve materially from current levels.

If you're watching

Consider adding if quarterly reports show margin expansion or revenue growth; avoid if EPS misses continue.

Keep on your radar

Next quarterly EPS and revenue results (due ~September 2026).
Management updates on Calavo acquisition integration progress.
Margin trends and operating cost metrics in upcoming reports.
Analyst revisions to EPS forecasts and target prices.